OmniComm Europe GmbH
OmniComm Systems, Inc.
Fort Lauderdale, FL, January 12, 2011 - OmniComm Systems, Inc., a global provider of eClinical solutions and services, today announced that it received Safe Harbor Certification effective December 30, 2010. OmniComm complies with the U.S.-EU Safe Harbor Framework and the U.S.-Swiss Safe Harbor Framework and meets the standards defined by the EU Directive on Data Protection.
"This certification gives assurances to our clients that OmniComm adheres to the strict data protection requirements as defined by the EU Directive on Data Privacy," said Dr. Yvonne Rollinger, Managing Director of the OmniComm European Headquarters. "Compliance to the Safe Harbor Principles helps to develop, foster and expand our business with the 27 EU member states and Switzerland, and it is an additional demonstration of the high quality and data privacy standards of OmniComm's superior Quality Management System."
The European Directive on Data Protection requires that transfers of personal data take place only to non-EU countries that provide an "adequate" level of privacy protection. The United States takes a different approach to data privacy than taken by the European Union. To diminish uncertainties and provide a more predictable framework for personal data transfers from the EU to the U.S., the U.S. Department of Commerce in consultation with the European Commission issued the Safe Harbor Framework in 2000. Certified Organizations must comply with the seven Safe Harbor Principles about Notice, Choice, Onward Transfer, Access, Security, Data Integrity and Enforcement. For more information please see http://www.export.gov/safeharbor.
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.
Safe Harbor Disclaimer
Safe Harbor Disclaimer Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.